BN
Bionik Laboratories Corp.
BNKL · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.25K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 5.71%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 54.83%
Net margin 273.99%
FCF margin 187.64%
Quality
10 /100
Poor ROIC 448.84%
ROA 147.11%
Asset turnover 0.54x
Debt
21 /100
High Current ratio 1.20x
Int. coverage -45.16x
Debt/Equity N/A
Stability
31 /100
Unstable Beta 9.36x
Rev. volatility 43.41%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BNKL
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Richard Paul Russo Jr.
Employees
12
Headquarters
Watertown